Pharmaceutical Innovation Hits the Wall: How Open Innovation Can Help. Life-Science-Initiatives.pdf (Objet application/pdf) SB2011_draft_October.pdf (Objet application/pdf) University of Cambridge Joins Eli Lilly’s “Open Innovation Drug Discovery Platform” The University of Cambridge has partnered up with global pharmaceutical company Eli Lilly and Company in an active collaboration programme helping to find and develop potential new medicines, particularly in the areas of greatest need.
Gianluigi Cuccureddu comments on the challenges and possibilities of the initiative. Next to the University of Cambridge over 60 European institutions have so far joined the initiative, according to the press release. 11-1429-strategy-for-uk-life-sciences (Objet application/pdf)